Ligase Pharmaceutical Private Limited
About Ligase Pharmaceutical Private Limited
Data last updated:
Ligase Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74990DL2015PTC287615. Its GSTIN is 22AACCL9813D1ZU (Chhattisgarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajit Yadav and Harish Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at O – 74 Krishan Vihar, New Delhi, Delhi, India – 110086.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.49 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹89,409 (net margin 3.1%) and EBITDA of ₹1.3 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 94% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ligase Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressO – 74 Krishan Vihar, New Delhi, Delhi, India – 110086
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ligase Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ligase Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Ligase Pharmaceutical Private Limited, buy the company report.
Financials of Ligase Pharmaceutical Private Limited
FY 2025 filings availableLigase Pharmaceutical Private Limited reported revenue of ₹28.49 Lakh (up 403% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 403% growth in the latest year. EBITDA rose 188% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹89,409 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ligase Pharmaceutical Private Limited, buy the company report.
Board of directors of Ligase Pharmaceutical Private Limited
Ligase Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Yadav Also directs: MDGR Trade Private Limited | Director | 04 Mar 2022 | 4 Years 7 Months | Current |
| Harish Yadav | Director | 21 Apr 2022 | 4 Years 6 Months | Current |
Auditor
Ligase Pharmaceutical Private Limited is audited by PALSANIA AGRAWAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PALSANIA AGRAWAL & CO | FY 2021 | 006739C |
Shareholding
The shareholding of Ligase Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ligase Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ligase Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ligase Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ligase Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AACCL9813D1ZU | Chhattisgarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ligase Pharmaceutical Private Limited, buy the company report.
Recent activity
Ligase Pharmaceutical Private Limited has 6 board changes on record since 2022: 2 appointments and 4 cessations. The latest: Ajit Yadav ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Ligase Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 November 2015 (11+ years old) and is registered under CIN U74990DL2015PTC287615.
Ligase Pharmaceutical has 2 current directors:
- Ajit Yadav - Director
- Harish Yadav - Director
The latest financial statements of Ligase Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Ligase Pharmaceutical is 22AACCL9813D1ZU, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Ligase Pharmaceutical is U74990DL2015PTC287615. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ligase Pharmaceutical was incorporated on 20 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Ajit Yadav ceased to be Additional Director on 30 Sep 2022. Harish Yadav ceased to be Additional Director on 30 Sep 2022. Shardanand Sahni ceased to be Director on 27 Apr 2022. Ligase Pharmaceutical has 6 board changes on record in total.
The registered office of Ligase Pharmaceutical is at O – 74 Krishan Vihar, New Delhi, Delhi, India – 110086.
Ligase Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Ligase Pharmaceutical is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
